Matt delves into how psychedelics like psilocybin and LSD quiet the "Default Mode Network" to boost neuroplasticity. He describes these molecules as a "crowbar" that allows therapy to break deep-seated patterns of depression and reorganize the mind. Matt also reviews MDMA and ketamine trials for PTSD and trauma. While noting the brain's capacity for rapid change, he addresses research risks like the "blinding problem" and debunks microdosing myths. In essence, today’s episode presents a balan...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
Get summaries like this every morning.
Free AI-powered recaps of The Matt Walker Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.